Prelude Capital Management’s Select Medical SEM Stock Holding History

Prelude Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$604K	Sell	36,600 -195,105	-84%	-$3.21M	0.04%	450
2026 Q1	$3.77M	Buy	+231,705	New	+$3.63M	0.29%	85
2022 Q4	–	Sell	-37,144	Closed	-$442K	–	1576
2022 Q3	$442K	Buy	37,144 +2,123	+6%	+$30.2K	0.02%	698
2022 Q2	$446K	Sell	35,021 -5,544	-14%	-$71.2K	0.01%	866
2022 Q1	$524K	Buy	+40,565	New	+$536K	0.02%	838
2021 Q2	–	Sell	-34,241	Closed	-$629K	–	1920
2021 Q1	$629K	Buy	34,241 +8,986	+36%	+$147K	0.02%	788
2020 Q4	$376K	Buy	25,255 +1,511	+6%	+$19.7K	0.01%	827
2020 Q3	$266K	Buy	+23,744	New	+$234K	0.01%	600
2019 Q2	–	Sell	-1,125	Closed	-$9K	–	2092
2019 Q1	$9K	Hold	1,125	–	–	﹤0.01%	1477
2018 Q4	$9K	Buy	+1,125	New	+$10.8K	﹤0.01%	1393
2017 Q1	–	Sell	-15,171	Closed	-$108K	–	1744
2016 Q4	$108K	Buy	+15,171	New	+$106K	0.01%	802
2016 Q3	–	Sell	-22,107	Closed	-$129K	–	1793
2016 Q2	$129K	Buy	+22,107	New	+$146K	0.02%	658
2014 Q1	–	Sell	-19,488	Closed	-$122K	–	2081
2013 Q4	$122K	Sell	19,488 -10,208	-34%	-$49.8K	0.02%	793
2013 Q3	$129K	Sell	29,696 -650	-2%	-$2.97K	0.02%	694
2013 Q2	$134K	Buy	+30,346	New	+$134K	0.03%	542

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Prelude Capital Management's SEM Position: Q2 2026 in Review

Prelude Capital Management reduced its Select Medical (SEM) stake by 84% in Q2 2026, selling an estimated $3.21M and leaving 36,600 shares worth $604K. The position accounts for 0.04% of the portfolio, ranked #450.

Prelude Capital Management first reported a position in SEM in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.77M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Prelude Capital Management held 36,600 shares of Select Medical worth $604K as of Q2 2026.
Prelude Capital Management sold 195,105 Select Medical shares in Q2 2026, an estimated $3.21M.
Select Medical made up 0.04% of Prelude Capital Management's portfolio in Q2 2026, its #450 holding.
Prelude Capital Management first reported a position in Select Medical in Q2 2013 and has held it in 15 quarters since.
Prelude Capital Management's Select Medical position peaked at $3.77M in Q1 2026.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.